A Clinical Trial to Study the Effect of Salsaradi Gana Bhavit Haritaki in Patients with High Glucose Levels in Blood.

A clinical study of Salsaradi Gana Bhavit Haritaki in the management of Sthoola Pramehi (Diabetes Mellitus – Type – II). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054652

Enrollment

Registered

2023-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of above 18 years and below 65 years. 2. Classical signs and symptoms of Prameha. 3. Fasting plasma glucose = 200 mg/dl, Post Prandial glucose level = 300 mg/dl. 4. Both insulin-dependent and non-insulin-dependent Type – II Diabetes Mellitus patients will be included. 5. Both newly diagnosed patients on allopathic treatment will be included in this study. 6. The dose of Modern Medicine will be adjusted and tapered during the period of trial as per need. 7. Patients having BMI (Body Mass Index) = 25 and = 35 will be taken for the study.

Exclusion criteria

Exclusion criteria: 1. Patients of either sex in the age group of above 18 years and below 65 years. 2. Classical signs and symptoms of Prameha. 3. Fasting plasma glucose = 200 mg/dl, Post Prandial glucose level = 300 mg/dl. 4. Both insulin-dependent and non-insulin-dependent Type – II Diabetes Mellitus patients will be included. 5. Both newly diagnosed patients on allopathic treatment will be included in this study. 6. The dose of Modern Medicine will be adjusted and tapered during the period of trial as per need. 7. Patients having BMI (Body Mass Index) = 25 and = 35 will be taken for the study.

Design outcomes

Primary

Measure	Time frame
Improvement in laboratorial parameters as well as signs and symptoms of Sthoola Pramehi (Type – II Diabetes Mellitus).Timepoint: 40 Days	—

Secondary

Measure	Time frame
To improve quality of life by reducing high blood glucose level.Timepoint: 40 days	—

Countries

India

Contacts

Public ContactDr Surendra A Soni

Government Akhandanand Ayurveda College, Ahmedabad

surendraasoni@gmail.com9408441150

Outcome results